Ernie Andberg has a little more free time on his hands these days. The long-time “emerging medical device companies” equity analyst for Feltl & Co. in Minneapolis has not seen a lot of companies emerging lately. In fact, they’ve been disappearing all together. Case in point: Medtronic Inc.’s (NYSE: MDT) deal last week to acquire […]
That bodes well for Minnesota's publicly traded medical device companies, including St. Jude Medical Inc., SurModics Inc. and Rochester Medical Corp., which were among the first to begin reporting fourth-quarter and yearly results last week.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Golden Valley-based OptumHealth in September 2008 stopped letting patients go to UW Hospital for kidney transplants, the hospital's largest transplant program, saying the program's success rate was too low. The company was paying for 16 percent of transplants at the hospital, second only to the federal health plan Medicare.